Skip to main content Skip to main navigation menu Skip to site footer
Page Header Logo
  • ABOUT THE JOURNAL
    • Focus and scope
    • Editorial Management Process
  • EDITORIAL POLICY
    • Ethical Publication Standards
    • Open Access Policy
    • Anti-plagiarism Policy
    • Copyright
    • Policy for Journal Archiving
    • Claim Policy
  • AUTHORS
    • Guidelines to Authors
    • Sending and Receiving Papers
    • Structure and Content of Articles
    • Article Evaluation Process
    • ORCID
    • coi_disclosure Colombia Médica ICMJE
    • Copyright Transfer Statement Colombia Médica
  • PEER REVIEW
    • Peer Review Process
    • Evaluation Forms
  • EDITORIAL TEAM
    • Editorial team
    • Contact
  • ARTICLES
    • Current
    • Archives
  • COLLECTIONS
Search
  • Register
  • Login
  1. Home /
  2. Archives /
  3. Vol 49 No 1 (2018): Colombia Cancer Epidemiology /
  4. Original Articles

Cancer incidence estimates and mortality for the top five cancer in Colombia, 2007-2011

  • Abstract
  • Keywords
  • Author Biographies
  • References

Abstract

Objective: To estimate incidence and mortality for 25 cancer sites in Colombia, for the period 2007-2011.

Methods: Cases and age-standardized cancer incidence rates per 100,000 person-years were estimated based on incidence/mortality ratios in areas with a population-based cancer registry with published data in Cancer Incidence in Five Continents, volume X (Cali, Pasto, Bucaramanga and Manizales). Mortality age-standardized rates per 100,000 were based on official cause of death statistics. Cause of death statistics and population projections were provided by the National Administrative Department of Statistics (DANE). Incidence and mortality rates were calculated by department, cancer type and sex.

Results: The annual number of expected cancer cases (all cancers combined) for the period 2007-2011 was 62,818 with a total of 32,653 deaths. A total of 1,322 new childhood cancer cases was expected (0-14 years). The most frequently diagnosed incident cancers were prostate (46.5 per 100,000 person-years) and breast (33.8 per 100,000 person-years) cancers. The highest cancer mortality rates were observed for males in stomach cancer (14.2) and for females for breast cancer (9.9).

Conclusions: Colombia presented higher estimates of incidence and mortality for breast and prostate cancer, as well as a proportion of cancers related to infection such as stomach and cervical cancer. More than 50% of the cancer burdens were attributed to these neoplasms. Time trends in cancer incidence can only be reliably evaluated based on long-term information from high-quality population-based cancer registries.

 

Authors

  • Constanza Pardo Instituto Nacional de Cancerología, Bogotá, D.C., Colombia.
  • Ricardo Cendales Instituto Nacional de Cancerología, Bogotá, D.C., Colombia.

Downloads

Download data is not yet available.

Keywords

  • Incidence
  • mortality
  • cancer
  • epidemiology
  • Colombia

Author Biographies


, Instituto Nacional de Cancerología, Bogotá, D.C., Colombia.

Grupo de Vigilancia Epidemiológica del Cáncer, Instituto Nacional de Cancerología, Bogotá, D.C., Colombia.


, Instituto Nacional de Cancerología, Bogotá, D.C., Colombia.

Grupo de Vigilancia Epidemiológica del Cáncer, Instituto Nacional de Cancerología, Bogotá, D.C., Colombia (acardocen@yahoo.com).

References

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer; 2013. Acceso: 24 de mayo de 2017. Disponible en: http://globocan.iarc.fr.

Piñeros M, Znaor A, Mery L, Bray F. A global cancer surveillance framework within noncommunicable disease surveillance: making the case for population-based cancer registries. Epidemiol Rev. 2017;39(1):161–9.

de Vries E, Pardo C, Arias N, Bravo LE, Navarro E, Uribe C, et al. Estimating the cost of operating cancer registries: Experience in Colombia. Cancer Epidemiol. 2016;45:S13-S19.

Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer. 2002;38(1):99-166.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86.

Piñeros M, Ferlay J, Murillo R. Incidencia estimada y mortalidad por cáncer en Colombia, 1995-1999. Bogotá, D.C: Instituto Nacional de Cancerología; 2005.

Pardo C, Cendales R. Incidencia estimada y mortalidad por cáncer en Colombia 2002-2006. Bogotá, D.C: Instituto Nacional de Cancerología; 2010.

Pardo C, Cendales R. Incidencia estimada, mortalidad y prevalencia por cáncer en Colombia 2007-2011. Bogotá, D.C: Instituto Nacional de Cancerología; 2015.

WHO. National cancer control programmes: policies and managerial guidelines. Second ed. Geneva, Switzerland: World Health Organization; 2002.

Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, et al. (eds) Cancer Incidence in Five Continents, Vol X. Lyon: IARC; 2013. Disponible en http://ci5.iarc.fr/CI5-X/Default.aspx.

WHO. Demographic and socioeconomic statistics: Census and civil registration coverage. Data by country. Global Health Observatory data repository, WHO; 2017. Acceso: 21 de junio de 2017. Disponible en http://apps.who.int/gho/data/node.main.121?lang=en.

Cendales R, Pardo C. La calidad de certificación de la mortalidad en Colombia, 2002-2006. Rev Salud Publica . 2011;13(2):229-38.

Alvis LF, Acuña ML, Sánchez QP. Información preliminar sobre el reporte de cáncer y el proceso de atención en Colombia. Boletín de información técnica especializada. 2015; 1(4):1-12.

Valencia, O, Lopes G, Sánchez P, Acuña L, Uribe D, González J. Incidence and prevalence of cancer in Colombia: the methodology used matters. J Glob Oncol. 2018; 1-4.

de Vries E, Pardo C, Henríquez G, Piñeros M. Discrepancias en manejo de cifras de cáncer en Colombia. Rev Colomb Cancerol. 2016;20(1):45–7.

de Vries E, Pardo C, Wiesner C. Active versus passive cancer registry methods make the difference: case report from Colombia. J Glob Oncol. 2018; 4:1-3. doi: 10.1200/JGO.17.00093.

Departamento Administrativo Nacional de Estadística. Estimaciones 1985-2005 y Proyecciones 2005-2020 nacional y departamental desagregadas por sexo, área y grupos quinquenales de edad. Acceso el 30 de junio de 2014. Disponible en https://www.dane.gov.co/index.php/poblacion-y-demografia/series-de-poblacion.

Loos AH, Bray F, McCarron P, Weiderpass E, Hakama M, Parkin DM. Sheep and goats: separating cervix and corpus uteri from imprecisely coded uterine cancer deaths, for studies of geographical and temporal variations in mortality. Eur J Cancer. 2004; 40(18): 2794-803.

Capocaccia R. Relationships between incidence and mortality in non-reversible diseases. Stat Med. 1993;12(24):2395-415.

Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374-403.

Cendales R, Pardo C. Modelo para la estimación de incidencia de cáncer en el orden departamental en Colombia, 2002-2006. Rev Colomb Cancerol. 2012;16(1):5-15.

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108.

Sierra MS, Soerjomataram I, Antoni S, Laversanne M, Piñeros M, de Vries E, Forman D. Cancer patterns and trends in Central and South America. Cancer Epidemiol. 2016;44 (Suppl 1):S23-S42.

Murillo R, Wisner C, Acosta J, Piñeros M; Pérez JJ, Orozco M. Modelo de cuidado del paciente con cáncer. Bogotá D.C: Instituto nacional de Cancerología; 2015.

Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F et al. Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype. Eur J Cancer. 2014;50(7): 1330–1344.

Piñeros M, Pardo C, Gamboa O, Hernández G. Atlas de mortalidad por cáncer en Colombia. Bogotá D.C: Instituto Nacional de Cancerología; 2010.

Cueva P, Sierra MS, Bravo LE, Forman D. Etiology of stomach cancer (C16) in Central and South America. In: Cancer in Central and South America. Lyon: International Agency for Research on Cancer; 2016. Citado: 2017 Jun 29. Disponible en: http://www-dep.iarc.fr/CSU_resources.htm.

Chlebowski RT, Manson JE, Anderson GL, Cauley JA, Aragaki AK, Stefanick ML, et al. Estrogen plus progestin and breast, cancer incidence and mortality in the Women’s Health Initiative Observational Study. J Natl Cancer Inst. 2013;105:526-35.

Kabat GC, Jones JG, Olson N, Negassa A, Duggan C, Ginsberg M, Rohan, TE. Risk factors for breast cancer in women biopsied for benign breast disease: A nested case-control study. Cancer epidemiol. 2010;34(1):34-9.

Ministerio de Salud y Protección social. Sistemas de Información –PAI. Presentación Coberturas PAI 2014. 2014. Consulta: 10 de noviembre de 2017. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/PAI/Rol%20de%20la%20EAPB%20en%20PAI.%20Enero%20%202014.pdf.

Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012; 30(suppl 5): F12-F23.

Bray F, Znaor A, Cueva P, Korir A, Swaminathan R, Ullrich A, et al. Planning and Developing Population-Based Cancer Registration in Low- and Middle-Income Settings. Lyon, France: International Agency for Research on Cancer; 2014.

Parkin DM. The evolution of the population-based cancer registry. Nat Rev Cancer. 2006;6(8):603–12.

Tangka FK, Subramanian S, Edwards P, Cole-Beebe M, Parkin DM, Bray F, et al. Resource requirements for cancer registration in areas with limited resources: analysis of cost data from four low-and middle-income countries. Cancer Epidemiol. 2016;45:S50-S58.

  • PDF
  • PDF (Español) (Español (España))
  • Full Text
  • HTML (Español) (Español (España))
Published
2018-03-31
Submitted
2017-10-06
| 2121 |
How to Cite
Pardo, C., & Cendales, R. (2018). Cancer incidence estimates and mortality for the top five cancer in Colombia, 2007-2011. Colombia Médica, 49(1), 16-22. https://doi.org/10.25100/cm.v49i1.3596
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX
Issue
Vol 49 No 1 (2018): Colombia Cancer Epidemiology
Section
Original Articles

Copyright (c) 2018 Revista Colombia Medica

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use

Online ISSN: 1657-9534
Make a Submission

Bibliographics database

Full-text database

Citation Index

Bibliographical information system

Memberships

Licencia Creative Commons
This work is under License Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) .

Indexed

.
0.82
2018CiteScore
 
 
68th percentile
Powered by  Scopus
.
Information
  • For Authors
Universidad del Valle
Universidad del Valle
  • Cali - Colombia
  • © 1994 - 2020
Dirección:
  • Ciudad Universitaria Meléndez
  • Calle 13 # 100-00
  •  
  • Sede San Fernando
  • Calle 4B N° 36-00
PBX:
  • +57 2 3212100
  • Línea gratuita: 018000 22 00 21
  • A.A.25360
Redes Sociales:

2020 Universidad del Valle - Vigilada MinEducación

//Go to www.addthis.com/dashboard to customize your tools